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Background: Epithelial-mesenchymal transition (EMT) is reported to promote airway remodeling in
asthmatics, which is the main histological change that causes complex and severe symptoms in asth-
matics. However, little is known about whether EMT also plays a role in acute exacerbations of asthma
evoked by respiratory tract infections.
Methods: A human lung adenocarcinoma line, A549, was incubated with TGF-b1 at 10 ng/ml to induce
EMT. Then the cells were stimulated with CpG ODN. Expression of surface and intracellular molecules
was analyzed by ﬂow cytometry. IL-6, IL-8 and MCP-1 in the culture supernatant were measured by
Cytometric Bead Assay, and the expression of mRNA was quantitated by real-time PCR. CpG ODN uptake
was analyzed by ﬂow cytometry.
Results: The culture supernatant levels of IL-6, IL-8 and MCP-1 and the expression of mRNA for these
cytokines in CpG ODN-stimulated A549 cells that had undergone EMT was signiﬁcantly higher compared
to those that had not. Addition of ODN H154, a TLR9-inhibiting DNA, signiﬁcantly suppressed the CpG
ODN-induced production of those cytokines. However, ﬂow cytometry found the level of TLR9 expression
to be slightly lower in A549 cells that had undergone EMT compared to those that had not. On the other
hand, CpG ODN uptake was increased in cells that had undergone EMT.
Conclusions: EMT induction of A549 cells enhanced CpG ODN uptake and CpG ODN-induced production
of IL-6, IL-8 and MCP-1. These results suggest that EMT plays an important role in exacerbation in
asthmatics with airway remodeling by enhancing sensitivity to extrinsic pathogens.
Copyright © 2016, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Bronchial asthma is an allergic disease of the airways that is
increasing throughout theworld, with signiﬁcant impacts on public
health. Based on WHO estimates, 334 million people suffer from
asthma,1 and in Japan the prevalence rates of asthmatic symptoms
and current asthma among Japanese adults have been reported to
be as high as 10.1% and 4.2%, respectively.2 While most asthmatics'
symptoms can be controlled well with inhaled corticosteroids,
symptoms of severe asthmatics remain difﬁcult to control and can
even become fatal, especially when acute exacerbation is evoked.ses, Clinical Research Center,
pital, 3-1-1 Takeoka, Kiyose,
zukawa).
ety of Allergology.
rgology. Production and hosting by ElseThe known potential causes of acute exacerbation include in-
fections, allergens, occupational exposure, hormones, drugs, exer-
cise, stress and air pollutants.3 Among these, bacterial infection is
reported to be frequently involved in asthma exacerbation in
adults4,5 as well as young children.6
Especially in severely asthmatic bronchi, airway remodeling is
often identiﬁedasoneof themainhistological changes, togetherwith
airway inﬂammation. Histopathological ﬁndings of airway remod-
eling include goblet cell metaplasia/hyperplasia, subepithelial
ﬁbrosis, reticular basement membrane thickening and extracellular
matrix deposition, increased airway smooth muscle mass and
vascular changes.7 Airway remodeling leads to irreversible airﬂow
limitation8 and airway hyperresponsiveness,9 which are the main
physiological changes seen in severe asthmatics. Indeed, the degrees
of subepithelial layer thickening,10 ﬁbroblast accumulation and
airwaysmoothmusclehypertrophy11are associatedwith the severity
of asthma. One of the underlying causes of these histological changes
is thought to be epithelial-mesenchymal transition (EMT).12,13vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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typically transformed into mesenchymal cells.14,15 EMT is
commonly classiﬁed into three types: type 1 is seen in organ
development, type 2 is associated with tissue regeneration and
organ ﬁbrosis and type 3 occurs in tumor invasion and meta-
stasis.14e16 Recent studies suggest that type 2 EMT promotes airway
remodeling in asthmatics12,13 and that a potent in vitro EMT-
inducer, TGF-b,17 is associated with airway remodeling in
asthma.18 However, little is known whether or not, and how,
changes in the characteristics of airway epithelial cells caused by
EMT may be involved in acute exacerbation of asthma evoked by
respiratory tract infections.
In the ﬁrst line of defense against microbial pathogens, Toll-like
receptors (TLR) recognize pathogen-associated molecular patterns
leading to activation of the innate immune system.19 It is widely
accepted that unmethylated CpGmotifs are recognized by TLR9 and
act as pathogen-associated molecular patterns,20e22 and synthetic
oligodeoxynucleotides with species-speciﬁc CpG DNA motifs (CpG
ODN) show the same effect as naturally-occurring CpG.22 There-
fore, we used CpG ODN in the present study and show that TGF-
b1einduced EMT of a human lung adenocarcinoma line, A549,
enhanced IL-6, IL-8 andMCP-1 production in response to CpG ODN.
Methods
Reagents
The following reagents were purchased as indicated: recombi-
nant human TGF-b1 (PEPRO TECH, Rocky Hill, NJ, USA) (Sigma-
eAldrich, St. Louis, MO, USA); ODN 2006 (B-class CpG ODN,
50tcgtcgttttgtcgttttgtcgtt30), control ODN (B-class ODN,
50tgctgcttttgtgcttttgtgctt30), ODN H154 (50cctcaagcttgagggg30)22
and FAM-conjugated CpG ODN (SigmaeAldrich); PBS and FBS
(Thermo Fisher Scientiﬁc, Waltham, MA, USA); and D-MEM/Ham's
F-12 medium (Wako Pure Chemical Industries, Osaka, Japan); and
dexamethasone and ethanol (Wako Pure Chemical Industries).
The following antibodies were purchased as indicated: PE-
conjugated mouse anti-human E-cadherin mAb (IgG1k, clone
67A4) (BD Biosciences, San Jose, CA, USA); APC-conjugated mouse
anti-human N-cadherin mAb (IgG1k, clone 8C11), APC-conjugated
rat anti-human TLR9 mAb (IgG2ak, clone eB72-1665), APC-conju-
gated mouse anti-human CD14 mAb (IgG1k, clone 61D3), PE-
conjugated mouse IgG1k (clone P3.6.2.8.1), APC-conjugated mouse
IgG1k (clone P3.6.2.8.1) and APC-conjugated rat IgG2ak (clone
eBR2a) (eBioscience, San Diego, CA, USA); PE-Cy7-conjugated
mouse anti-human CD205 mAb (IgG1k, clone HD30) (Miltenyi
Biotec, Bergisch Gladbach, Germany); and PE-Cy7-conjugated
mouse IgG1k (clone MOPC-21) (BioLegend, San Diego, CA, USA).
Cell line and culture
A human lung adenocarcinoma line, A549, was cultured in D-
MEM/Ham's F-12 medium containing 5% FBS, 100 U/ml penicillin
and 100 mg/ml streptomycin at 37 C, 5% CO2 until the experiments.
For induction of EMT, A549 at a cell density of 5  104 cells/ml
was seeded with TGF-b1 at 10 ng/ml in D-MEM/Ham's F-12 me-
dium containing 5% FBS, 100 U/ml penicillin and 100 mg/ml strep-
tomycin and incubated for 3 days at 37 C, 5% CO2.
Flow cytometric analysis
Expression of cell-surface E-cadherin, N-cadherin, CD14 and
CD205 was analyzed by ﬂow cytometry. After incubation with or
without TGF-b1, as previously described, 1  105e106 cells were
washed with FACS buffer (PBS containing 3% FBS), blocked withhuman IgG at 1 mg/ml and incubated with 25 mg/ml of PE-
conjugated mouse anti-human E-cadherin mAb/APC-conjugated
mouse anti-human N-cadherin mAb or isotype control in FACS
buffer on ice for 30 min. After washing with FACS buffer, the cells
were resuspended in FACS buffer and analyzed by FACSVerse (BD
Biosciences). For each sample, at least 10,000 eventswere collected,
and dot plots and histograms were generated using FlowJo (Tree
Star Inc., Ashland, OR, USA).
Expression of intracellular TLR9 was analyzed by ﬂow cytom-
etry. After incubation with or without TGF-b1, 1  105e106 cells
werewashedwith FACS buffer and blockedwith human IgG at 1 mg/
ml, followed by ﬁxation and permeabilization using Fixation/Per-
meabilization Solution (BD Biosciences) according to the manu-
facturer's protocol. The cells were washed and then incubated with
20 mg/ml of APC-conjugated rat anti-human TLR9 mAb or isotype
control in Perm/Wash buffer on ice for 30 min. Then the cells were
resuspended in the FACS buffer and analyzed by FACSVerse.
To analyze the cellular uptake of CpG, EMT-induced cells were
incubated with FAM-conjugated CpG ODN or unconjugated CpG
ODN at 10 mg/ml in D-MEM/Ham's F-12 medium for 24 h at 37 C
and shielded from light. Then 1  105e106 cells were washed with
FACS buffer and analyzed by FACSVerse.
Quantitation of A549-derived cytokines
EMT-induced cells in D-MEM/Ham's F-12 medium were incu-
bated with CpG ODN or control ODN at 1, 3,10 and 30 mg/ml for 48 h
for concentration analysis, or at 10 mg/ml for 6, 12, 24 and 48 h for
time-course analysis. The levels of IL-6, IL-8 and MCP-1 in the
culture supernatants were measured by Cytometric Bead Assay
(CBA; BD Biosciences) according to the instructions of the manu-
facturer. The supernatants were stored at 80 C until assay. For
inhibition assay, EMT-induced cells were incubated with CpG ODN
at 10 mg/ml and ODN H154 at 0, 1, 3, 10, 30 and 100 mg/ml or
dexamethasone at 0, 1, 10, and 100 pM for 24 h, and the culture
supernatants were subjected to CBA.
Real-time quantitative PCR analysis
EMT-induced cells were incubated with CpG ODN or control
ODN at 10 mg/ml for 4 h. Then the total RNAwas extracted from the
cultured cells using an RNeasy Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer's instructions. The extracted mRNA
was reverseetranscribed to cDNA using an iScript cDNA Synthesis
Kit (Bio-Rad Laboratories, Hercules, CA, USA). Real-time PCR was
performed using primers and Taqman probes designed by Thermo
Fisher Scientiﬁc, Inc. Data were calculated by the DDCt method,
using the cDNA and, as a reference, b-actin cDNA. The relative
quantitation (RQ) values were calculated using the following
equation: RQ ¼ 2DDCt.
Statistics
Statistical analysis was performed using an unpaired two-tailed
t-test for pair-wise comparisons or by ANOVAwith Tukey's test for
multiple comparisons. Statistical signiﬁcance was deﬁned as a P
value of less than 0.05. All data are expressed as the mean ± SD of
3e6 independent experiments.
Results
TGF-b1 induced EMT in A549 cells
EMT induction by TGF-b1 in A549 alveolar epithelial cells has
been established.16 Using our materials, after incubation with TGF-
K. Kobayashi et al. / Allergology International 65 (2016) S45eS52 S47b1 the cells showed the typical morphology of the mesenchymal
phenotype: cell elongation, loss of cell polarity and reduced cellular
adhesion (data not shown). Additionally, we used ﬂowcytometry to
analyze for E-cadherin and N-cadherin cell-surface markers, which
are negative andpositivemarkers, respectively, of themesenchymal
cell-type.17,23,24 As reported, A549 cells cultured with TGF-b1
showed reduced E-cadherin expression and increased N-cadherin
expression (Fig. 1A) compared with the TGF-b1eunstimulated
control cells, and the percentage of E-cadherin-low, N-cadherin-
high cells quantitated using dot plots was signiﬁcantly increased
(Fig. 1B). These results indicate that TGF-b1 successfully induced
EMT in A549 cells.
EMT induction enhanced CpG ODN-induced production of IL-6, IL-8
and MCP-1 by A549 cells
Next, we investigated the effect of EMTon the responsiveness of
A549 cells to CpG ODN. As shown in Figure 2A, IL-6, IL-8 andMCP-1
production was signiﬁcantly increased with CpG ODN at 3e30 mg/
ml in A549 cells that had undergone EMT, but not in those that had
not (Fig. 2A). Time-course analysis showed that the difference in
production of those cytokines reached a maximum at 48 h after
treatment with CpG ODN (Fig. 2B). Similarly, expression of mRNA
for those cytokines by CpG ODN in EMT-induced A549 cells startedA
TGF-β )-( 
N-cadherin
E
-c
ad
he
rin
B
E-cadherin-low and N
TGF-β (-)
0
10
20
30
40
50
E-
ca
dh
er
in
-lo
w
 a
nd
N
-c
ad
he
rin
-h
ig
h 
ce
lls
 (%
)
Fig. 1. Induction of EMT in A549 cells by TGF-b1. A: After incubation with (right dot plot) or
anti-E-cadherin antibody and APC-conjugated anti-N-cadherin antibody. Representative tw
cadherin antibody from three independent experiments are shown, with the gates for an
represents the percentage of cells in each quadrant. B: The percentages of E-cadherin-low, N
(n ¼ 3). ***P < 0.001 vs. cells incubated without TGF-b1.to increase within 1 h after the addition of CpG ODN (data not
shown), and it became statistically signiﬁcant at 4 h (Fig. 2C). Such
enhancement of mRNA expression by CpG ODN was not observed
in A549 cells without EMT induction (Fig. 2C). We have to note that
the baseline cytokine/chemokine production was upregulated only
by EMT induction, even without CpG ODN stimulation, although it
was not statistically signiﬁcant (Fig. 2A,C). However, interaction
between TGF-b1 treatment and CpG ODN stimulation was statis-
tically signiﬁcant for each cytokine/chemokine at the protein
(Fig. 2A, P < 0.001) and mRNA (Fig. 2C, P < 0.01) levels, indicating a
synergistic effect of EMT induction and CpG ODN stimulation, even
when we take into consideration the upregulation of baseline
cytokine/chemokine production by EMT induction. Therefore, we
conclude that EMT induction enhanced CpG ODN-induced pro-
duction of IL-6, IL-8 and MCP-1 by A549 cells at the transcriptional
level.
ODN H154, a DNA inhibitor for TLR9, suppressed production of IL-6,
IL-8 and MCP-1 by EMT-induced A549 cells in response to CpG ODN
TLR9 is a receptor for CpG DNA that mediates the cellular
response to CpG DNA20e22 and also recognizes synthetic ODNs that
contain species-speciﬁc CpG motif signaling.22 Therefore, we next
used ODN H154, a selective DNA inhibitor for TLR9,25,26 to elucidate-FGT β (+)
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rin
-cadherin-high cells
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***
without TGF-b1 (left dot plot) at 10 ng/ml, A549 cells were stained with PE-conjugated
o-dimensional dot plots of cells stained with anti-E-cadherin antibody and anti-N-
alyzing E-cadherin-low, N-cadherin-high cells shown in B. The number in each gate
-cadherin-high cells determined using the gates in A are shown. Bars represent the SD
Fig. 2. A: Levels of IL-6, 8 and MCP-1 in the A549 cell culture supernatant after stimulation with CpG ODN at 1, 3, 10 and 30 mg/ml or control ODN at 30 mg/ml for 48 h following
incubation with (-) or without (▫) TGF-b1 at 10 ng/ml. Bars represent the SD (n ¼ 3). n.s., not signiﬁcant; *P < 0.05; **P < 0.01; ***P < 0.001 vs. cells stimulated with control ODN. B:
Levels of IL-6, 8 and MCP-1 in the A549 cell culture supernatant after stimulation with CpG ODN (B) or control ODN (C) at 10 mg/ml for 6, 12, 24 and 48 h following EMT induction.
Bars represent the SD (n ¼ 4). *P < 0.05, **P < 0.01, ***P < 0.001 vs. cells stimulated with control ODN. C: Expression levels of IL-6, 8 and MCP-1 mRNA after stimulation of A549 cells
with CpG ODN (-) or control ODN (▫) at 10 mg/ml for 4 h following incubation with or without TGF-b1 at 10 ng/ml. Bars represent the SD (n ¼ 4). n.s., not signiﬁcant; *P < 0.05;
**P < 0.01 vs. cells stimulated with control ODN.
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CpG ODN caused by EMT. Addition of ODN H154 to the culture
signiﬁcantly suppressed production of IL-6, IL-8 and MCP-1 by
EMT-induced A549 cells in response to CpG ODN (Fig. 3A). The
levels of IL-6 and IL-8 were almost completely suppressed to the
levels of control ODN. These results indicate that the cytokine
production evoked by CpG ODN is mediated by TLR9 and that TLR9
is essential in the mechanism for enhanced sensitivity to CpG ODN
caused by EMT.
Similarly, dexamethasone signiﬁcantly suppressed the cytokine
production by EMT-induced A549 cells to the control levels
(Fig. 3B).TLR9 expression was decreased by EMT
Next, we examined the expression level of intracellular TLR9 by
ﬂow cytometry. Flow cytometry found the TLR9 expression level to
be slightly lower in A549 cells that had undergone EMT compared
to those that had not (Fig. 4AeC). Real-time PCR found that
expression of mRNA for TLR9 was also signiﬁcantly decreased in
cells incubated with TGF-b1 for 48 h compared to those without
TGF-b1 (Fig. 4D). Collectively, although TLR9 is important in themechanism of enhanced responsiveness of EMT-induced A549 cells
to CpG ODN, the basic expression level of TLR9 was not upregulated
by that EMT induction.
CpG ODN uptake was increased by EMT
Finally, we examined the possibility that increased CpG ODN
uptake by EMT-induced A549 cells was involved in the cells'
enhanced sensitivity to CpG ODN. Flow cytometry found that CpG
uptake was increased in A549 cells incubated with TGF-b1
compared to the control cells (Fig. 5AeC). However, EMT induction
caused no change in cell-surface expression of CD14 or CD205, two
CpG receptors reported to be important in CpG uptake and known
to be expressed in macrophages, dendritic cells, respectively27,28
(data not shown).
Discussion
Today, althoughmost asthmatics' symptoms are well-controlled
by the use of inhaled corticosteroids, the existence of severe asth-
matics remains a major problem. Airway remodeling is a major
histological characteristic in severe asthmatics and has been shown
Fig. 3. A: Levels of IL-6, 8 and MCP-1 in the A549 cell culture supernatant after incubation with ODN H154 at 0, 1, 3, 10, 30 and 100 mg/ml in addition to CpG ODN or control ODN at
10 mg/ml for 24 h following induction of EMT. Bars represent the SD (n ¼ 3). n.s., not signiﬁcant; *P < 0.05; **P < 0.01; ***P < 0.001 vs. cells stimulated with CpG ODN but without
ODN H154. B: Levels of IL-6, 8 and MCP-1 in the A549 cell culture supernatant after incubation with dexamethasone (Dex) at the indicated concentrations and CpG ODN at 10 mg/ml
for 24 h following induction of EMT. Control samples were incubated with control ODN at 10 mg/ml and ethanol. Bars represent the SD (n ¼ 3). n.s., not signiﬁcant; *P < 0.05;
**P < 0.01; ***P < 0.001 vs. cells stimulated with CpG ODN and ethanol but without dexamethasone.
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as one origin of airway remodeling.12,13 Therefore, in the present
study we used A549 cells and CpG ODN to elucidate the effect of
TGF-b-induced EMT on cytokine production by airway epithelial
cells in response to microbial stimuli by investigating cytokine
production and the underlying mechanism(s).
We showed that EMT induction enhanced production of IL-6, IL-
8 and MCP-1 by A549 cells at both the mRNA and protein levels in
response to CpG ODN (Fig. 2AeC). IL-6 is a very well-known pro-
inﬂammatory cytokine and is reported to promote Th2 effector cell
expansion. By suppressing the function of CD4þCD25þ regulatory
T cells IL-6 inhibits peripheral tolerance,29 which may lead to
worsening of asthmatic symptoms. In mice, overexpression of IL-6
in the airways induced airway remodeling with subepithelial
ﬁbrosis.30 From our present study, we can speculate that epithelial
cells that had undergone EMT in severe asthmatics are at least
partially responsible for overexpressed IL-6 in the airways at the
time of acute exacerbations related to respiratory tract infections,
and this upregulation of IL-6 may accelerate Th2 responses as well
as airway remodeling under the circumstances. On the other hand,
IL-8 and MCP-1, also known as Chemokine (CeC motif) ligand 2
(CCL2), are well-known chemotactic factors for neutrophils,31
monocytes,32 mast cells,33 ﬁbrocytes34 and Th17 cells35 in the
lung. It is widely accepted that a high neutrophil count in the
sputum is a predictive factor for steroid-resistant, severe asthma,36
and an increased neutrophil count and elevated IL-8 level in
induced sputum correlated closely with the severity of asthma.37
Together with our present results, IL-8 produced by EMT-induced
airway epithelial cells during respiratory tract infections may play
an important role in steroid-resistant severe asthma by recruiting
neutrophils and other inﬂammatory cells. MCP-1 is more than just a
chemoattractant, since it induces mast cell degranulation38 and
airway hyperreactivity.38,39 It is noteworthy that EMT induction
itself by 72-h culture with TGF-b promoted the basic production of
cytokines even without CpG ODN stimulation. EMT-promotedupregulation of mRNA for IL-6 was previously reported using a
similar method to ours with A549 cells and TGF-b,40 but we showed
here that EMT induction alone also elevated other cytokines, i.e., IL-
8 and MCP-1, at both the mRNA and protein levels. Taken together,
these mediators, namely, IL-6, IL-8 and MCP-1, that were upregu-
lated by EMT induction itself and by EMT-enhanced responsiveness
to stimulation with CpG ODN, may exacerbatedat least in
partdasthmatic symptoms related to respiratory tract infections.
The protein levels of other mediators including those directly
related to Th2 inﬂammation, e.g., IL1-b, IL-4, IL-5, IL-13, IFN-a, TNF-
a, RANTES, periostin, IL-25, IL-33 and GM-CSF, were not signiﬁ-
cantly increased in EMT-induced A549 cells by exposure to CpG
ODN.
In spite of down-regulation of TLR9 expression in EMT-induced
A549 cells (Fig. 4AeD), we showed that an inhibitory DNA for TLR9,
ODN H154,25 signiﬁcantly suppressed production of IL-6, IL-8 and
MCP-1 by EMT-induced A549 cells in response to CpG ODN (Fig. 3),
indicating that TLR9 is essential for the enhanced response to CpG
ODN brought about by EMT induction. TLR9 is a receptor that
recognizes unmethylated CpG motifs, which are widely found in
bacterial DNA and known to activate the innate immune sys-
tem.19e22 Although the precise frequency and impact of bacterial
infections on exacerbations of asthma have not been fully exam-
ined, respiratory infections are the biggest cause of acute exacer-
bation of asthma.5,41 In addition, histopathological changes in the
airway, such as airway remodeling, can impair mucociliary clear-
ance,7,42 a change that may increase bacterial infections in asth-
matics.43 Thus, our present ﬁnding of upregulation of the TLR9-
mediated response to a microbial component, CpG ODN, in EMT-
induced A549 cells might partially explain the mechanism(s) of
increased susceptibility of severe asthmatics' airways to extrinsic
pathogens.
Our ﬁnding of increased CpG uptake due to EMT induction
(Fig. 5AeC) may explain one mechanism of EMT-induced A549
cells' enhanced sensitivity to CpG ODN. However, the expression
Fig. 4. Expression of TLR9 by A549 cells. A: After incubation with (solid line) or without (dashed line) TGF-b1 at 10 ng/ml, A549 cells were ﬁxed, permeabilized and stained with
APC-conjugated anti-TLR9 antibody. Expression of intracellular TLR9 was analyzed by ﬂow cytometry. Representative histograms from four independent experiments are shown.
The shaded area indicates cells stained with the control antibody. B: The histograms in A are shown separately, with the gates for analyzing TLR-9-high cells in C. The numbers
shown in each gate are the percentages of cells belonging to each gate. C: The percentages of TLR-9-high cells determined using the gates in B are shown. Bars represent the SD
(n ¼ 4). *P < 0.05 vs. cells incubated without TGF-b1 (▫). D: After incubation with (-) or without (▫) TGF-b1 for 4, 24 and 48 h, the total RNA was extracted from the cultured cells
and the relative quantitation values of mRNA for TLR9 were calculated. Bars represent the SD (n ¼ 3e6). n.s., not signiﬁcant; *P < 0.05 vs. cells incubated without TGF-b1.
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expressed in macrophages and dendritic cells, respectively,27,28
were not altered on EMT-induced A549 cells. There may be a yet-
unknown receptor for CpG ODN uptake on A549 cells, but the
mechanism underlying this increased uptake of CpG ODN by A549
cells needs to be further elucidated.
Airway remodeling was reported to be directly associated with
airway hyperresponsiveness by a physiological mechanism: the
remodeled airway lumen can be easily narrowed or occluded
without excessive muscle shortening compared to the normal
airway.9 Our present data suggest that airway remodeling induced
by EMT might promote reactivity to extrinsic pathogens by
inducing cytokine production that would lead to prolonged and
exaggerated airway inﬂammation. Thus, our data add a new
mechanism(s) by which severe asthmatics' airways with remod-
eling are more susceptible to exacerbation induced by respiratorytract infections. We must note that while bacterial DNA containing
CpG motifs is recognized by TLR9, rhinovirus, the most common
pathogen found in acute exacerbation of asthma,44,45 is recognized
by TLR2, 7 and 8.46 Therefore, the effect of EMT on reactivity of
these receptors needs to be further studied to strengthen our hy-
pothesis. In addition, our study investigated only B-class ODN but
not other classes, and we used a human lung adenocarcinoma line,
A549, in which EMT induced by TGF-b has been established and
well-studied. In order to strengthen the case that our hypothesis is
universal in human biology, our results need to be reproduced
using human primary bronchial epithelial cells with other ODN
classes as well.
In conclusion, EMT induction in A549 cells enhanced CpG ODN
uptake and subsequent production of IL-6, IL-8 and MCP-1. These
results suggest that EMT is closely related to airway remodeling,
especially in severe asthmatics, and may play an important role in
Fig. 5. CpG ODN uptake by A549 cells. A: After incubation with (solid line) or without (dashed line) TGF-b1 at 10 ng/ml, A549 cells were incubated with FAM-conjugated CpG ODN
at 10 mg/ml for 24 h and then analyzed by ﬂow cytometry. A representative histogram from three independent experiments is shown. The shaded area indicates cells incubated with
unconjugated CpG ODN. B: The histograms in A are shown separately, with the gates for analyzing cells that showed high CpG ODN uptake. The numbers in each gate are the
percentages of cells belonging to the gate. C: The percentages of cells that showed high CpG ODN uptake determined using the gates in B are shown. Bars represent the SD (n ¼ 3).
*P < 0.05 vs. cells incubated without TGF-b1.
K. Kobayashi et al. / Allergology International 65 (2016) S45eS52 S51exacerbation in those patients by enhancing sensitivity to extrinsic
pathogens. EMT is reported to play important roles not only in
airway remodeling in asthmatics, but also in other major respira-
tory diseases such as lung ﬁbrosis and lung cancer. Our present
ﬁndings suggest the existence of novel mechanism(s) by which
respiratory diseases are exacerbated in response to extrinsic
pathogens.
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